NCT04315831View on ClinicalTrials.gov

Safety and Effectiveness of Transdermal Buprenorphine in Cancer Pain

CompletedOBSERVATIONAL
Enrollment

83

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Cancer
Interventions
DRUG

Transdermal Buprenorphine

Intervention will be applied for patients with moderate to severe cancer pain

Trial Locations (1)

Unknown

Chang Gung Memorial Hospital- Linko Branch, New Taipei City

All Listed Sponsors
collaborator

Chang Gung Memorial Hospital

OTHER

collaborator

Changhua Christian Hospital

OTHER

collaborator

Taipei Medical University Shuang Ho Hospital

OTHER

lead

Taiwan Mundipharma Pharmaceuticals Ltd.

INDUSTRY

NCT04315831 - Safety and Effectiveness of Transdermal Buprenorphine in Cancer Pain | Biotech Hunter | Biotech Hunter